What's new? Log in Free sign up

Core Laboratories (CLB) News and press releases

Company Profile

News

From Benzinga Pro

Citigroup Maintains Neutral on Core Laboratories, Raises Price Target to $26

News, Price Target, Analyst Ratings

Citigroup analyst Scott Gruber maintains Core Laboratories (NYSE:CLB) with a Neutral and raises the price target from $21 to $26.

Core Laboratories Q4 Adj. EPS $0.20, Inline, Sales $127.57M Miss $130.34M Estimate

Core Laboratories (NYSE:CLB) reported quarterly earnings of $0.20 per share which met the analyst consensus estimate. This is unchanged from the same period last year. The company reported quarterly sales of $127.57

Earnings Scheduled For February 1, 2023

Companies Reporting Before The Bell • Novo Nordisk (NYSE:NVO) is expected to report quarterly earnings at $0.85 per share on revenue of $6.84 billion.

Core Laboratories's Earnings: A Preview

Core Lab Announces Proposed Redomestication To The United States

Core Laboratories N.V. (NYSE: "CLB US") ("Core", "Core Lab", or the "Company") announces the Company's Board of Directors has approved a plan to reorganize the Company's

Benzinga's Top Ratings Upgrades, Downgrades For January 9, 2023

Upgrades, Downgrades, Initiation, Intraday Update, Analyst Ratings

B of A Securities Upgrades Core Laboratories to Neutral

News, Upgrades, Analyst Ratings

B of A Securities analyst Chase Mulvehill upgrades Core Laboratories (NYSE:CLB) from Underperform to Neutral.

Press releases

From Benzinga Pro

CORE LAB REPORTS FOURTH QUARTER AND FULL YEAR 2022 RESULTS FROM CONTINUING OPERATIONS

Earnings, Commodities, Press Releases

FOURTH QUARTER REVENUE OF $128 MILLION; UP SLIGHTLY SEQUENTIALLYFOURTH QUARTER OPERATING INCOME OF $16 MILLION; EX-ITEMS OF $15 MILLION, UP 10% SEQUENTIALLYFOURTH QUARTER OPERATING MARGIN, EX-ITEMS, OF 12% WITH

CORE LAB ANNOUNCES PROPOSED REDOMESTICATION TO THE UNITED STATES

Commodities, Press Releases

AMSTERDAM, Jan. 17, 2023 /PRNewswire/ -- Core Laboratories N.V. (NYSE: "CLB US") ("Core", "Core Lab", or the "Company") announces the Company's Board of Directors has approved a plan

CORE LABORATORIES' FOURTH QUARTER 2022 WEBCAST AT 7:30 A.M. CST / 2:30 P.M. CET ON FEBRUARY 2, 2023

Commodities, Press Releases

AMSTERDAM, Jan. 4, 2023 /PRNewswire/ -- Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its fourth quarter 2022 conference call over the Internet at 7:30 a.m. CST / 2:30

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.